相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis
Gerald Jordan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia
Kotaro Hatta et al.
SCHIZOPHRENIA RESEARCH (2014)
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis
David Fraguas et al.
SCHIZOPHRENIA RESEARCH (2014)
Clozapine's Role in the Treatment of First-Episode Schizophrenia
Gary Remington et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Comparison of Treatment Response in Second-Episode Versus First-Episode Schizophrenia
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Predictors of clinical remission following a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables
Ignacio Diaz et al.
PSYCHIATRY RESEARCH (2013)
Randomized trial of clozapine vs. risperidone in treatment-naive first-episode schizophrenia: Results after one year
Javier Sanz-Fuentenebro et al.
SCHIZOPHRENIA RESEARCH (2013)
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
Oliver D. Howes et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis
G. Faber et al.
EUROPEAN PSYCHIATRY (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial
Ragy R. Girgis et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis
Ofer Agid et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia
Kotaro Hatta et al.
SCHIZOPHRENIA RESEARCH (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
Bruce J. Kinon et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
Atheir I. Abbas et al.
PSYCHOPHARMACOLOGY (2009)
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial
Robert A. Rosenheck et al.
SCHIZOPHRENIA RESEARCH (2009)
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial
Rene S. Kahn et al.
LANCET (2008)
Comparative remission rates of schizophrenic patients using various remission criteria
Romain Beitinger et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone? - A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting
Takefumi Suzuki et al.
PSYCHOPHARMACOLOGY (2007)
On the concept of remission in schizophrenia
Stefan Leucht et al.
PSYCHOPHARMACOLOGY (2007)
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: A CATIE study
T. Scott Stroup et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Aripiprazole for treatment-resistant schizophrenia: Results of a multicenter, randomized, double-blind, comparison study versus perphenazine
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Effectiveness of switching antipsychotic medications
Susan M. Essock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia
Shon W. Lewis et al.
SCHIZOPHRENIA BULLETIN (2006)
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
TS Stroup et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia
JM Kane et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clozapine as a first treatment for schizophrenia
MG Woerner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol
JA Lieberman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
A meta-analysis of the efficacy of second-generation antipsychotics
JM Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia
PFJ Schulte
CLINICAL PHARMACOKINETICS (2003)
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
J Geddes et al.
BRITISH MEDICAL JOURNAL (2000)
A comparison of the effects of quetiapine ('Seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment
RA Emsley et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)